Vision Marine Technologies Announces Reverse Stock Split

Vision Marine Technologies Inc. (NASDAQ: VMAR), today announced that the Company’s board of directors (the “Board”) approved 1 for 40 reverse stock split of the Company’s common shares. The reverse stock split is expected to become effective when the market opens on January 14, 2026 (the “Effective Date”) and the Company’s common shares will begin […]

EVs for All America Releases New Report Showing Republican Resistance to EVs Easing Amid Job and China Concerns

New research shows Republican hostility to EVs easing, end of federal EV subsidies curbing EV demand, strong EV sales potential in multifamily housing, 49 percent of younger (under 45) open to buying Chinese-made vehicles, and sharply polarized views of Elon Musk and Tesla. President Trump remains controversial among auto consumers, with only 28 percent rating

Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer

(NASDAQ:ACHV), SEATTLE and VANCOUVER, British Columbia, Jan. 12, 2026 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for treatment of nicotine dependence for smoking cessation, today announced that it has confirmed the promotion of Mark Rubinstein, M.D., from Interim Chief

Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer

Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer Experienced medical executive advances to permanent role following successful leadership as Interim CMO GlobeNewswire January 12, 2026 SEATTLE and VANCOUVER, British Columbia, Jan. 12, 2026 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the

TurboTenant Honored with Built In’s 2026 ‘Best Places to Work’ Award

Leading Property Management Platform Recognized as Best Startup to Work for in Colorado TurboTenant, the nation's leading all-in-one property management platform, today announced it has been recognized by Built In as one of the Best Places to Work in 2026. The annual awards honor employers across the U.S. whose benefits and compensation set the standard

Sify reports Consolidated Financial Results for Q3 FY 2025-26

(NASDAQ:SIFY), Revenues of INR 11596 Million. EBITDA of INR 2470 Million. Loss for the period INR 329 Million. CHENNAI, India, Jan. 12, 2026 (GLOBE NEWSWIRE) — DETAILS OF EARNING CALL January 13, 2026 | 8:30 AM ET | 07:00 PM IST Participant Dial in: To join: +1-888-506-0062 (Toll Free in the U.S. or Canada) or

ACCENT DATA PRESENTED AT 2026 ASCO GASTROINTESTINAL CANCER SYMPOSIUM

(Other OTC:INNMF),(OTC US:INNMF),(AUST:ATX.AX), HIGHLIGHTS Results from the Phase 2a ACCENT trial in pancreatic cancer have been presented at the specialist conference ASCO Gastrointestinal Cancer Symposium Updated data analysis continues to show that Narmafotinib combination compares favourably with gemcitabine and Abraxane combination alone Melbourne, Australia, Jan. 12, 2026 (GLOBE NEWSWIRE) — Amplia Therapeutics Limited (ASX:ATX; OTCQB:INNMF),

Actuate Therapeutics Reports Positive Follow-Up Data from its Randomized Controlled Phase 2 Trial Demonstrating Extended Long-Term Overall Survival Benefit with Elraglusib Plus Chemotherapy for Metastatic Pancreatic Cancer in Oral Presentation at ASCO GI 2026

(NasdaqGM:ACTU), Phase 2 study met its primary endpoint, demonstrating statistically significant improved overall survival with elraglusib plus gemcitabine/nab-paclitaxel versus chemotherapy alone Elraglusib combination reduced the risk of death by 38% compared with gemcitabine/nab-paclitaxel alone, with increased durable survival observed beyond 24 months CHICAGO and FORT WORTH, Texas, Jan. 12, 2026 (GLOBE NEWSWIRE) — Actuate Therapeutics,

Defense Spending Is Accelerating the Commercialization of Quantum Computing

(NasdaqGM:VWAV),(NYSE:IONQ),(NASDAQ:KTOS),(NASDAQ:RGTI),(NYSE MKT:UAVS), NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) — Market News Updates News Commentary – Quantum computing is moving from the lab into real-world military use, and defense organizations are paying close attention. Unlike traditional computing, quantum systems can process extraordinarily complex variables at once, which is highly relevant for modern military operations. Applications

Sify reports Consolidated Financial Results for Q3 FY 2025-26

Sify reports Consolidated Financial Results for Q3 FY 2025-26 GlobeNewswire January 12, 2026 Revenues of INR 11596 Million. EBITDA of INR 2470 Million. Loss for the period INR 329 Million. CHENNAI, India, Jan. 12, 2026 (GLOBE NEWSWIRE) — DETAILS OF EARNING CALL January 13, 2026 | 8:30 AM ET | 07:00 PM IST Participant Dial

Scroll to Top